Excited to finally know in detail how our favorite cross-reactive mAb PAM1.4 interacts with VAR2CSA. Fantastic work led by @kaituowang and the DISCOVERY team @TLavstsen at @UCPH_Research
https://t.co/8ZJkycSS2X
@mikebok I didn't know you worked with Daphnias 😍! I used to take care of a couple of colonies, one of Machrothrix and another of Ylyocryptus and have loved water fleas ever since 🤗
Last chance to apply for a position in my team @warwickmed. If your interested in unconventional T cells and their interactions with major pathogens, Plasmodium (Malaria), Mycobacterium (TB) or viruses (SARS and CMV) then please apply! @gdTforum https://t.co/5US2AR7VDX
Earth has left a safe #climate state, and is on the brink of irreversible disaster.
New @ScienceMagazine study by @dvdmckay, @jrockstrom, & colleagues.
https://t.co/jDN4QTJlXs
🚨THIS IS AN EMERGENCY. OUR LIVES DEPEND ON A FAST AND FAIR TRANSITION TO A FOSSIL-FREE WORLD. 🚨
Inspired by @ICOPAnhagen? Recent PhD in molecular parasitology? Interested in transmission? 🦟 We’re hiring soon… 1/2 postdocs w molecular genetics background (bonus immunology). DM me for deets. #malaria#sporozoite. Join us in Sydney ☀️
Is almost time for our symposium ⬇️ at #ICOPAnhagen! You will hear about an often ignored T cell population #tcell#gammadelta#vdTCR and its importance in malaria and beyond!
Dr. Pikka Jokelainen - Chair of ICOPA 2022, 1st Vice-President of @WorldFedPara, President of @_SBSP_ and Prof. Lars Hviid - president of @DParasitology look forward to welcoming you to #ICOPA2022! 🧡
👉 Late bird? Register now: https://t.co/Gfnf7aEf0a
Countdown mode! Feeling excited to attend an in person scientific congress after more than 2 years! Can't wait to catch up with a few friends/colleagues and share some of the lab's latest data! Bonus:I also get to go back home 🇸🇪 for a few days! #ICOPAnhagen#parasitology
✅ Three days until #ICOPAnhagen!
How much do you know about the process of evolving a new pentameric ligand-gated ion channel receptor? 🤔
Join the session “Anti-parasitic activity: compounds and targets” at #ICOPA2022!
https://t.co/FcqaHCm8Pw
@hanniepower@karolinskainst@PLOSONE I am late for twitter (joined like a year ago) and only now see this one!!! Glad to hear you found our work (part of my PhD project) interesting and decided to help us spread the word!!
Stay tuned for an ongoing expanded study exploring some of the ideas we discussed in this paper in relation to VAR2CSA-specific naturally acquired immunity! 🧵 6/6
These results suggest that broadly cross-reactive antibodies to VAR2CSA target conformational epitopes that are not properly reproduced by smaller antigens (including the current vaccine candidates) consisting of domains or regions of the larger, full-length protein 🧵 5/6